` 300485 (Beijing Science Sun Pharmaceutical Co Ltd) vs Shanghai Composite Comparison - Alpha Spread

300485
vs
S
Shanghai Composite

Over the past 12 months, Beijing Science Sun Pharmaceutical Co Ltd has outperformed Shanghai Composite, delivering a return of +42% compared to the Shanghai Composite's +31% growth.

Stocks Performance
300485 vs Shanghai Composite

Loading
300485
Shanghai Composite
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
300485 vs Shanghai Composite

Loading
300485
Shanghai Composite
Difference
www.alphaspread.com

Performance By Year
300485 vs Shanghai Composite

Loading
300485
Shanghai Composite
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Beijing Science Sun Pharmaceutical Co Ltd vs Peers

Shanghai Composite
300485
RYI
AVGR
BROG
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Beijing Science Sun Pharmaceutical Co Ltd
Glance View

Market Cap
5.4B CNY
Industry
Biotechnology

Beijing Science Sun Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of bio-pharmaceutical products. The company is headquartered in Beijing, Beijing and currently employs 584 full-time employees. The company went IPO on 2015-06-26. The Company' products can be divided into cardiovascular series, immune regulation series, nervous system series and other natural or biotech pharmaceuticals. Its products include small capacity injection and freeze-dried powder injection.

Intrinsic Value
6.25 CNY
Overvaluation 45%
Intrinsic Value
Price ¥11.28
Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett